AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLSD
  4. [8-K] Clearside Biomedical, Inc. Reports Material Event

[8-K] Clearside Biomedical, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source:

Stock CLSD logo
Clearside Biomed

NASDAQ:CLSD

CLSD Rankings

#5503 Ranked by Market Cap
N/A Ranked by Dividends

CLSD Latest News

Aug 26, 2025
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
Jul 23, 2025
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada
Jul 17, 2025
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline
Jun 17, 2025
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
May 21, 2025
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum

CLSD Latest SEC Filings

Aug 8, 2025
[10-Q] Clearside Biomedical, Inc. Quarterly Earnings Report
Aug 4, 2025
[DEF 14A] Clearside Biomedical, Inc. Definitive Proxy Statement
Jul 25, 2025
[PRE 14A] Clearside Biomedical, Inc. Preliminary Proxy Statement

CLSD Stock Data

31.97M
68.40M
12.88%
14.85%
2.52%
Biotechnology
Pharmaceutical Preparations
United States
ALPHARETTA